Ctt Pharmaceutical Holdings, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on September 22, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on September 24, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on September 18, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on September 14, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on September 8, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on September 3, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on September 2, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on August 28, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on August 20, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on August 20, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on August 17, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on August 12, 2026.
OQB
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on August 7, 2026.